Previous Close | 1.1000 |
Open | 1.1000 |
Bid | 1.0600 x 100 |
Ask | 1.1500 x 100 |
Day's Range | 1.0900 - 1.1300 |
52 Week Range | 0.9750 - 1.8900 |
Volume | |
Avg. Volume | 57,837 |
Market Cap | 34.406M |
Beta (5Y Monthly) | -0.65 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -1.2000 |
Earnings Date | Aug 08, 2024 - Aug 12, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 2.00 |
Co-Diagnostics ( NASDAQ:CODX ) First Quarter 2024 Results Key Financial Results Net loss: US$9.31m (loss widened by 62...
Co-Diagnostics, Inc. (NASDAQ:CODX) Q1 2024 Earnings Call Transcript May 9, 2024 Co-Diagnostics, Inc. misses on earnings expectations. Reported EPS is $-0.31204 EPS, expectations were $-0.21. CODX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and welcome to the […]
Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced financial results for the quarter ended March 31, 2024.